Top 10 Companies To Invest In Right Now

Popular Posts: Follow Insider Buying Into These Cheap StocksGet Paid by Following Insiders2 Small Bank Stocks With Huge Upside Recent Posts: Buy These 2 Small Banks for Big Bucks 2 Small Bank Stocks With Huge Upside Bargain-Hunt Like a Private Equity Guru With These 3 Stocks View All Posts

Marty Whitman of Third Avenue Value once said that if he could find a quality financial institution trading around 80% of tangible book value, the results were likely to be very positive. That statement has never been truer than it is today.

Top 10 Companies To Invest In Right Now: Enterprise Products Partners LP (EPD)

Enterprise Products Partners L.P. (Enterprise), incorporated on April 9, 1998, owns and operates natural gas liquids (NGLs) related businesses of Enterprise Products Company (EPCO). The Company is a North American provider of midstream energy services to producers and consumers of natural gas, NGLs, crude oil, refined products and certain petrochemicals. Its midstream energy asset network links producers of natural gas, NGLs and crude oil from supply basins in the United States, Canada and the Gulf of Mexico with domestic consumers and international markets. Its midstream energy operations include natural gas gathering, treating, processing, transportation and storage; NGL transportation, fractionation, storage, and import and export terminals; crude oil gathering and transportation, storage and terminals; offshore production platforms; petrochemical and refined products transportation and services; and a marine transportation business that operates on the United States in land and Intracoastal Waterway systems and in the Gulf of Mexico. Its assets include approximately 50,000 miles of onshore and offshore pipelines; 200 million barrels of storage capacity for NGLs, petrochemicals, refined products and crude oil; and 14 billion cubic feet of natural gas storage capacity. In addition, its asset portfolio includes 24 natural gas processing plants, 21 NGL and propylene fractionators, six offshore hub platforms located in the Gulf of Mexico, a butane isomerization complex, NGL import and export terminals, and octane isobutylene production facilities. The Company operates in five business segments: NGL Pipelines & Services; Onshore Natural Gas Pipelines & Services; Onshore Crude Oil Pipelines & Services; Offshore Pipelines & Services, and Petrochemical & Refined Products Services.

NGL Pipelines & Services

The Company’s NGL Pipelines & Services business segment includes its natural gas processing plants and related NGL m arketing activities; approximately 16,700 miles of NGL pipel! ines; NGL and related product storage facilities; and 14 NGL fractionators. This segment also includes its import and export terminal operations. At the core of its natural gas processing business are 24 processing plants located across Colorado, Louisiana, Mississippi, New Mexico, Texas and Wyoming. Natural gas produced at the wellhead (especially in association with crude oil) contains varying amounts of NGLs. Once the mixed component NGLs are extracted by a natural gas processing plant, they are transported to a centralized fractionation facility for separation into purity NGL products. Once processed, this natural gas is available for sale through its natural gas marketing activities. Its NGL marketing activities generate revenues from the sale and delivery of NGLs it takes title to through its natural gas processing activities and open market and contract purchases from third parties. Its NGL marketing activities utilize a fleet of approximately 670 railcars, the majori ty of which are leased from third parties.

The Company’s NGL pipelines transport mixed NGLs and other hydrocarbons from natural gas processing facilities, refineries and import terminals to fractionation plants and storage facilities; distribute and collect NGL products to and from fractionation plants, storage and terminal facilities, petrochemical plants, export facilities and refineries, and deliver propane to customers along the Dixie Pipeline and certain sections of the Mid-America Pipeline System. Revenues from its NGL pipeline transportation agreements are based upon a fixed fee per gallon of liquids transported multiplied by the volume delivered. Certain of its NGL pipelines offer firm capacity reservation services. It collects storage revenues under its NGL and related product storage contracts based on the number of days a customer has volumes in storage multiplied by a storage fee. In addition, it charges customers throughput fees based on volumes delivered into and subsequently withdrawn from storage. Its ! principal! NGL pipelines include Mid-America Pipeline System, South Texas NGL Pipeline System, Seminole Pipeline, Dixie Pipeline, Chaparral NGL System, Louisiana Pipeline System, Skelly-Belvieu Pipeline, Promix NGL Gathering System, Houston Ship Channel pipeline, Rio Grande Pipeline, Panola Pipeline and Lou-Tex NGL Pipeline. It operates its NGL pipelines with the exception of the Tri-States pipeline.

The Company’s NGL operations include import and export facilities located on the Houston Ship Channel in southeast Texas. It owns an import and export facility located on land it leases from Oiltanking Houston LP. Its import facility can offload NGLs from tanker vessels at rates up to 14,000 barrels per hour depending on the product. During the year ended December 31, 2012, its average combined NGL import and export volumes were 132 thousand barrels per day. In addition to its Houston Ship Channel import/export terminal, it owns a barge dock also located on the Houston Shi p Channel, which can load or offload two barges of NGLs or other products simultaneously at rates up to 5,000 barrels per hour.

The Company owns or have interests in 14 NGL fractionators located in Texas and Louisiana. NGL fractionators separate mixed NGL streams into purity NGL products. The primary sources of mixed NGLs fractionated in the United States are domestic natural gas processing plants, crude oil refineries and imports of butane and propane mixtures. Mixed NGLs sourced from domestic natural gas processing plants and crude oil refineries are transported by NGL pipelines and by railcar and truck to NGL fractionation facilities.

The Company’s NGL fractionation facilities process mixed NGL streams for third party customers and support its NGL marketing activities. It earns revenues from NGL fractionation under fee-based arrangements, including a level of demand-based fees. At its Norco facility in Louisiana, it performs fractionatio n services for certain customers under percent-of-liquids co! ntracts. ! Its fee-based fractionation customers retain title to the NGLs, which it processes for them. Its NGL fractionators include Mont Belvieu fractionator, Shoup and Armstrong fractionator, Hobbs NGL fractionator, Norco NGL fractionator, Promix NGL fractionators and BRF fractionators.

Onshore Natural Gas Pipelines & Services

The Company’s Onshore Natural Gas Pipelines & Services business segment includes approximately 19,900 miles of onshore natural gas pipeline systems, which provide for the gathering and transportation of natural gas in Colorado, Louisiana, New Mexico, Texas and Wyoming. It leases salt dome natural gas storage facilities located in Texas and Louisiana and own a salt dome storage cavern in Texas, which are integral to its pipeline operations. This segment also includes its related natural gas marketing activities.

The Company’s onshore natural gas pipeline systems and storage facilities provide for the gathering and tra nsportation of natural gas from producing regions, such as the San Juan, Barnett Shale, Permian, Piceance, Greater Green River, Haynesville Shale and Eagle Ford Shale supply basins in the western United States. In addition, these systems receive natural gas production from the Gulf of Mexico through coastal pipeline interconnects with offshore pipelines. Its onshore natural gas pipelines receive natural gas from producers, other pipelines or shippers at the wellhead or through system interconnects and redeliver the natural gas to processing facilities, local gas distribution companies, industrial or municipal customers, storage facilities or to other onshore pipelines.

Its onshore natural gas pipelines generates revenues from transportation agreements under which shippers are billed a fee per unit of volume transported multiplied by the volume gathered or delivered. Its onshore natural gas pipelines offer firm capacity reservation services whereby the shipper p ays a contractually stated fee based on the level of through! put capac! ity reserved in its pipelines whether or not the shipper actually utilizes such capacity. Under its natural gas storage contracts, there are typically two components of revenues monthly demand payments, which are associated with a customer’s storage capacity reservation and paid regardless of actual usage, and storage fees per unit of volume stored at its facilities. The Company’s natural gas marketing activities generate revenues from the sale and delivery of natural gas obtained from third party well-head purchases, regional natural gas processing plants and the open market.

Onshore Crude Oil Pipelines & Services

The Company’s Onshore Crude Oil Pipelines & Services business segment includes approximately 5,100 miles of onshore crude oil pipelines, crude oil storage terminals located in Oklahoma and Texas, and its crude oil marketing activities. Its onshore crude oil pipeline systems gather and transport crude oil in New Mexico, Oklahoma and Texas to refineries, centralized storage terminals and connecting pipelines. Revenue from crude oil transportation is based upon a fixed fee per barrel transported multiplied by the volume delivered.

The Company owns crude oil terminal facilities in Cushing, Oklahoma and Midland, Texas, which are used to store crude oil volumes for it and its customers. Under its crude oil terminaling agreements, it charges customers for crude oil storage based on the number of days a customer has volumes in storage multiplied by a contractual storage fee. With respect to storage capacity reservation agreements, it collects a fee for reserving storage capacity for customers at its terminals. In addition, it charges its customers throughput (or pumpover) fees based on volumes withdrawn from its terminals. It provides fee-based trade documentation services whereby it documents the transfer of title for crude oil volumes transacted between buyers and sellers at its terminals. The Company’s crude oil marketing activities generate revenues! from the! sale and delivery of crude oil obtained from producers or on the open market.

Offshore Pipelines & Services

The Company’s Offshore Pipelines & Services business segment serves active drilling and development regions, including deepwater production fields, in the northern Gulf of Mexico offshore Texas, Louisiana, Mississippi and Alabama. This segment includes approximately 2,300 miles of offshore natural gas and crude oil pipelines and six offshore hub platforms. Its offshore Gulf of Mexico pipelines provide for the gathering and transportation of natural gas or crude oil. Revenue from its offshore pipelines is derived from fee-based agreements whereby the customer is charged a fee per unit of volume gathered or transported multiplied by the volume delivered. Poseidon Oil Pipeline Company, L.L.C. (Poseidon), in which it has a 36% equity method investment, purchases crude oil from producers and shippers at a receipt point (at a fixed or index-base d price less a location differential) and then sells quantities of crude oil at onshore Louisiana locations (at the same fixed or index-based price, as applicable).

The Company’s offshore platforms are components of its pipeline operations. Platforms are used to interconnect the offshore pipeline network; provide means to perform pipeline maintenance; locate compression, separation and production handling equipment and similar assets, and conduct drilling operations during the initial development phase of an oil and natural gas property. Revenues from offshore platform services consist of demand fees and commodity charges. Revenue from commodity charges is based on a fixed-fee per unit of volume delivered to the platform multiplied by the total volume of each product delivered.

Petrochemical & Refined Products Services

The Company’s Petrochemical & Refined Products Services business segment consists of propylene fractionation plant s, pipelines and related marketing activities; a butane isom! erization! facility and related pipeline system; octane enhancement and isobutylene production facilities; refined products pipelines, including its Products Pipeline System, and related marketing activities, and marine transportation and other services.

The Company’s propylene fractionation and related activities consist of seven propylene fractionation plants (six located in Mont Belvieu, Texas and a seventh in Baton Rouge, Louisiana), propylene pipeline systems aggregating approximately 680 miles in length and related petrochemical marketing activities. This business includes an export facility and associated above-ground polymer grade propylene storage spheres located in Seabrook, Texas. Results of operations for its polymer grade propylene plants are dependent upon toll processing arrangements and petrochemical marketing activities. The toll processing arrangements include a base-processing fee per gallon (or other unit of measurement). Its petrochemical marketing activities include the purchase and fractionation of refinery grade propylene obtained in the open market and generate revenues from the sale and delivery of products obtained through propylene fractionation. The revenues from its propylene pipelines are based upon a transportation fee per unit of volume multiplied by the volume delivered to the customer. As part of its petrochemical marketing activities, it has refinery grade propylene purchase and polymer grade propylene sales agreements. Its butane isomerization business includes three butamer reactor units and eight associated deisobutanizer units located in Mont Belvieu, Texas, which comprise the commercial isomerization facility in the United States.

The Company’s commercial isomerization units convert normal butane into mixed butane, which is fractionated into isobutane, isobutane and residual normal butane. The uses of isobutane are for the production of propylene oxide, isooctane, isobutylene and alky late for motor gasoline. These processing arrangements inclu! de a base! -processing fee per gallon (or other unit of measurement). Its isomerization business also generates revenues from the sale of natural gasoline created as a by-product of the isomerization process. The Company owns and operates an octane enhancement production facility located in Mont Belvieu, Texas, which produces isooctane, isobutylene and methyl tertiary butyl ether (MTBE). The products produced by this facility are used in reformulated motor gasoline blends. The isobutane feedstocks consumed in the production of these products are supplied by its isomerization units. The Company owns a facility located on the Houston Ship Channel, which produces high purity isobutylene (HPIB). The feedstock for this plant is produced by its octane enhancement facility located at its Mont Belvieu complex. HPIB is used in the production of alkylated phenols used as antioxidants, lube oil additives, butyl rubber and resins.

Refined products pipelines and related activities cons ist of its Products Pipeline System, equity method investment in Centennial Pipeline LLC (Centennial) and refined products marketing activities. The Products Pipeline System transports refined products, and petrochemicals, such as ethylene and propylene and NGLs, such as propane and normal butane. These refined products are produced by refineries and include gasoline, diesel fuel, aviation fuel, kerosene, distillates and heating oil. Refined products also include blend stocks, such as raffinate and naphtha. Blend stocks are used to produce gasoline or as a feedstock for certain petrochemicals. The Centennial Pipeline intersects its Products Pipeline System near Creal Springs, Illinois, and loops the Products Pipeline System between Beaumont, Texas and south Illinois. In addition, it has refined products terminals located at Aberdeen, Mississippi and Boligee, Alabama adjacent to the Tombigbee River and on the Houston Ship Channel in Pasadena, Texas. Its related marketing acti vities generate revenues from the sale and delivery of refin! ed produc! ts obtained from third parties on the open market.

The Company’s marine transportation business consists of tow boats and tank barges, which are used to transport refined products, crude oil, asphalt, condensate, heavy fuel oil, liquefied petroleum gas and other petroleum products along inland and intracoastal the United States waterways. Its marine transportation assets service refinery and storage terminal customers along the Mississippi River, the intracoastal waterway between Texas and Florida and the Tennessee-Tombigbee Waterway system. It owns a shipyard and repair facility located in Houma, Louisiana and marine fleeting facilities in Bourg, Louisiana and Channelview, Texas. Other services consist of the distribution of lubrication oils and specialty chemicals and the bulk transportation of fuels by truck, in Oklahoma, Texas, New Mexico, Kansas and the Rocky Mountain region of the United States.

Advisors’ Opinion:

  • [By Lisa Levin]

    Enterprise Products Partners LP (NYSE: EPD) shares reached a new 52-week high of $69.77 after analysts at Credit Suisse upgraded the stock from Neutral to Outperform and raised the target price from $71 to $78.

  • [By Jon C. Ogg]

    Enterprise Products Partners L.P. (NYSE: EPD) was the beneficiary of an analyst upgrade at Credit Suisse on Wednesday. The firm’s John Edwards raised Enterprise Products to Outperform from Neutral, and the target was raised to $78, versus a $68.80 close.

  • [By David Dittman]

    Answer: Growth: Magna International, Ag Growth International Inc (TSX: AFN, OTC: AGGZF), NextEra Energy Inc (NYSE: NEE), Aqua America Inc (NYSE: WTR) and, at these levels, Chevron Corp (NYSE: CVX). I like Verizon too.

    Income: Brookfield Renewable Energy, Northeast Utilities (NYSE: NU), Enterprise Products Partners LP (NYSE: EPD), Plains All American Pipeline Partners LP (NYSE: PAA), Pembina Pipeline.

Top 10 Companies To Invest In Right Now: Mears Group PLC (MER)

Mears Group PLC (Mears Group) is a holding company. The principal activities of the Company are the provision of a range of outsourced services to the public and private sectors. The Company operated in three business segments: social housing, which provides a full repair and maintenance service to local authorities and other registered social housing landlords in the United Kingdom; domiciliary care, which provides personal care services to people in their own homes and mechanical and electrical (M&E), which consists of provision of design and build M&E services. The Company’s subsidiaries include Mears Limited, Haydon Mechanical & Electrical Limited, Scion Technical Services Limited, Scion Estates Limited, Jackson Lloyd Limited, Morrison Facilities Services Limited, Morrison Facilities Services Limited, Manchester Working Limited and Mears Home Improvements Limited. Effective August 13, 2013, Mears Group PLC acquired a 50% interest in Just Call 24/7 (UK) Ltd. Advisors’ Opinion:

  • [By John Heinzl]

    If you’re uncomfortable picking individual preferred shares, a diversified exchange-traded fund, such as CPD can be a good option. The fund, which has about $1.4-billion under management, holds more than 200 preferred shares, with banks and insurance companies accounting for more than half of the assets. The fund has a management expense ratio (MER) of 0.5%.

Top 10 Companies To Invest In Right Now: Novartis AG (NVS)

Novartis AG, incorporated on February 29, 1996, provides healthcare solutions. The Company is a multinational group of companies specializing in the research, development, manufacturing and marketing of a range of healthcare products led by pharmaceuticals. Its portfolio includes medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. The Company has five segments: Pharmaceuticals, which include patent-protected prescription medicines; Alcon, which include surgical, ophthalmic pharmaceutical and vision care products; Sandoz, which include generic pharmaceuticals; vaccines and diagnostics, which include human vaccines and blood-testing diagnostics, and consumer health, which include over-the-counter medicines (OTC) and Animal Health. On April 8, 2011, the Company acquired the remaining non-controlling interest in Alcon, Inc. In December 2013, Alliance Pharma plc announced that its wholl y owned subsidiary, Alliance Pharmaceuticals Limited, acquired all the United Kingdom and Republic of Ireland (ROI) rights to Lypsyl from Novartis AG.

In April 2011, Novartis sells global rights to Elidel, a medicine to treat atopic dermatitis to Meda. In March 2011, Novartis completes acquisition of majority stake in Zhejiang Tianyuan vaccines company in China. In March 2011, the Company acquired Genoptix, Inc. In October 2011, Novartis discontinues development of AGO178 for depressive disorder. In December 2011, the Company discontinues development of PRT128 for acute coronary syndrome and chronic coronary heart disease, and SMC021 for osteoporosis and osteoarthritis. In April 2011, Alcon’s portfolio of generic ophthalmic medicines sold through its Falcon business unit primarily in the United States.

Pharmaceuticals Division

The Company’s Pharmaceuticals Division researches, develops, manufactures, distributes and sells patented pr escription medicines in the therapeutic areas, such as Oncol! ogy; Primary Care, consisting of Primary Care medicines and Established Medicines, and Specialty Care, consisting of Ophthalmology, Neuroscience, Integrated Hospital Care, and Critical Care medicines. The Pharmaceuticals Division is organized into global business franchises responsible for the commercialization of various products, as well as Novartis Oncology, a business unit responsible for the global development and commercialization of oncology products, and Novartis Molecular Diagnostics, a business responsible for the development and commercialization of diagnostic tests and services related to its pharmaceuticals portfolio and therapeutic areas.

The Company’s Oncology products include Afinitor/Votubia, Exjade, Sandostatin SC/Sandostatin LAR , Femara , Zometa, Tasigna and Gleevec/Glivec. Gleevec/Glivec, which is a signal transduction inhibitor approved to treat patients with certain forms of chronic myeloid leukemia (CML) and gastrointestinal stromal tu mors (GIST). Tasigna is a signal transduction inhibitor of the tyrosine kinase activity of Bcr-Abl, KIT+ and the PDGF-receptor. Zometa is a treatment to reduce or delay skeletal-related events (SREs), including pathologic fracture, spinal cord compression, and/or requirement of radiation therapy or surgery to bone, in patients with bone metastases (cancer that has spread to the bones) from solid tumors and multiple myeloma. Femara is a once-daily oral aromatase inhibitor for the treatment of early stage or advanced breast cancer in postmenopausal women. Sandostatin SC/Sandostatin LAR is indicated for the treatment of patients with acromegaly, a chronic disease caused by over-secretion of pituitary growth hormone in adults. Sandostatin is also indicated for the treatment of patients with certain symptoms associated with carcinoid tumors and other types of gastrointestinal and pancreatic neuroendocrine tumors. Exjade is an oral iron chelator approved for the treatment of chron ic iron overload due to blood transfusions in patients over ! two years! of age who have a range of underlying anemias. Patients with congenital and acquired chronic anemia, such as thalassemia, sickle cell disease and myelodysplastic syndromes, require transfusions, which puts them at risk of iron overload. Afinitor/Votubia is an oral inhibitor of the mTOR pathway.

The Company’s Primary Care products include Arcapta Neohaler/Onbrez Breezhaler, Diovan, Exforge, Tekturna/Rasilez, Galvus, Reclast/Aclasta, Voltaren/Cataflam, Ritalin, Ritalin LA, Focalin and Focalin XR. Its Specialty Care products include Lucentis, Gilenya, Exelon, Extavia and Comtan, and Stalevo. Its Integrated Hospital Care include Zortress/Certican, Ilaris, Neoral and Myfortic.The Company’s Critical Care products include Xolair and Tobi Podhaler. As of December 31, 2011, the products under development includes ACZ885, which is being investigated for the secondary prevention of cardiovascular events and for the treatment of Diabetes Mellitus; AEB071 (sotrastaurin) is a low molecular weight, selective inhibitor of protein kinase-C (PKC); AFQ056 (mavoglurant) is a metabotropic glutamate receptor 5 (mGluR5) antagonist in Phase II development for the treatment of Parkinson’s disease levodopa-induced dyskinesia; AIN457 (secukinumab) is a human monoclonal antibody neutralizing interleukin-17A, a key pro-inflammatory cytokine expressed by TH17 cells and other types of white blood cells; BAF312 is an oral, second-generation sphingosine 1-phosphate receptor modulator in Phase II development for relapsing-remitting multiple sclerosis; DEB025 (alisporivir) is a cyclophilin inhibitor for the treatment of Hepatitis C virus infection (HCV); Gileny a line treatment for relapsing forms of MS; Exjade (deferasirox) is an oral iron chelator in development for use in patients with non-transfusion-dependent thalassemia (NTDT); INC424 (ruxolitinib) is an investigational Janus kinase (JAK) inhibitor, and Zortress/Certican (everolimus) is an mTOR inhibitor with immune/non-immune cell proliferation inhibition being d! eveloped ! for prevention of solid organ transplant rejection.

Alcon Division

The Company’s Alcon Division discovers, develops, manufactures, distributes and sells eye care products. Alcon is engaged in eye care with product offerings in Surgical, Ophthalmic Pharmaceuticals and Vision Care. In Surgical, Alcon develops, manufactures, distributes and sells ophthalmic surgical equipment, instruments, disposable products and intraocular lenses. In Pharmaceutical, Alcon discovers, develops, manufactures, distributes and sells medicines to treat chronic and acute diseases of the eye, as well as over-the-counter medicines for the eye. In Vision Care, Alcon develops, manufactures, distributes and sells contact lenses and lens care products.

Alcon’s Surgical portfolio includes the Infiniti vision system for cataract procedures, the Constellation vision system for retinal operations, and the AcrySof family of intraocular lenses (IOLs), including the AcryS of IQ, AcrySof IQ ReSTOR, AcrySof IQ Toric and AcrySof IQ ReSTOR Toric IOLs. During the year ended December 31, 2011, its Alcon Division launched the LenSx femtosecond laser, a technology in cataract surgery, which increases the precision and reproductibility for corneal incisions, capsulorhexis and lens fragmentation steps of the procedure. In addition, Alcon provides advanced viscoelastics, surgical solutions, surgical packs and other disposable products for cataract and vitreoretinal surgery.

Alcon Division’s Ophthalmic Pharmaceuticals business combines Alcon’s range of pharmaceuticals with selected ophthalmic products (excluding Lucentis) previously marketed by the Novartis Pharmaceuticals Division. The products treat chronic and acute diseases of the eye including glaucoma and allergies, as well as anti-infective/anti-inflammatory and dry eye treatments. our Alcon Division’s Ophthalmic Pharmaceuticals portfolio include Travatan Z solution and DuoTrav soluti on for the treatment of elevated intraocular pressure associ! ated with! glaucoma; Vigamox solution for bacterial conjunctivitis; Pataday solution for ocular itching associated with allergic conjunctivitis; and Nevanac suspension for eye inflammation following cataract surgery. Alcon launched a number of products during 2011, including Dailies Total 1 lenses, Opti-Free EverMoist Multi Purpose Disinfecting Solution, LenSx laser, AcrySof IQ ReSTOR Toric lens, AcrySof IQ Toric T6-T9 lens, Travatan BAK-free solution, DuoTrav BAK-free solution, Moxeza solution and Systane Balance eye drops.

Sandoz Division

The Company’s Sandoz Division is a global generic pharmaceuticals company that develops, manufactures, distributes and sells prescription medicines, as well as pharmaceutical and biotechnological active substances, which are not protected by valid and enforceable third-party patents. The Sandoz Division has activities in Retail Generics, Anti-Infectives, and Biopharmaceuticals and Oncology Injectables. In Retail Generics , Sandoz develops, manufactures and markets active ingredients and finished dosage forms of pharmaceuticals, as well as supplying active ingredients to third parties. In Anti-Infectives, Sandoz develops and manufactures active pharmaceutical ingredients and intermediates, mainly antibiotics, for internal use by retail generics and for sale to third-party customers. In Biopharmaceuticals, Sandoz develops, manufactures and markets protein- or other biotechnology-based products (biosimilars or follow-on biologics) and sells biotech manufacturing services to other companies.

In Oncology Injectables, Sandoz develops, manufactures and markets primarily cytotoxic products for the hospital market. During 2011, the Company launched generic docetaxel (Taxotere), higher-strength generic amlodipine-benazepril (Lotrel), generic meropenem (Merem) injection, and the formation of a women’s health portfolio with generic Seasonale, Nordette, Yaz and Yasmin. The product launched in various European countries included generic docetaxel, ge! neric ana! strazole (Arimidex), and valsartan/covalsartan (an early entry generic version of Novartis Pharmaceuticals’ Diovan/Co-Diovan).

Vaccines and Diagnostics Division

The Company’s Vaccines and Diagnostics Division researches, develops, manufactures, distributes and sells preventive vaccines and diagnostic tools. Novartis Vaccines is a global developer and manufacturer of human vaccines. Novartis Diagnostics is a blood testing and molecular diagnostics business dedicated to preventing the spread of infectious diseases through blood-screening tools that protect the world’s blood supply. Novartis Vaccines’ products include influenza, meningococcal, pediatric, adult and travel vaccines.

The Company’s influenza vaccines include Agrippal, Fluad, Fluvirin and Optaflu. Its Meningococcal Vaccines includes Menjugate and Menveo. Its travel vaccines include Encepur Children, Encepur Adults, Ixiaro and Rabipur/Rabavert. Its Pediatric Vaccines includ e Polioral and Quinvaxem.

Consumer Health

Consumer Health consists of two Divisions: OTC (over-the-counter medicines) and Animal Health. Each has its own research, development, manufacturing, distribution and selling capabilities. OTC offers readily available consumer medicine. Animal Health provides veterinary products for farm and companion animals.

OTC (over-the-counter medicines) offers products for the treatment and prevention of common medical conditions and ailments. OTC business focuses on a group of global brands in product categories that include treatments for cough/cold/respiratory (Triaminic, Otrivin, TheraFlu/NeoCitran), pain relief (Excedrin, Voltaren), digestive health (Benefiber, Prevacid24HR, Pantoloc Control), dermatology (Lamisil, Fenistil), and smoking cessation (Habitrol/Nicotinell).

Animal Health offers products and services focusing on both companion and farm animals (including cultivated fish). Key products for c ompanion animals include Atopica (atopic dermatitis manageme! nt), Dera! maxx and Onsior (pain relief), Fortekor (heart failure in dogs, chronic renal insufficiency in cats), and Sentinel/Milbemax/Interceptor (intestinal parasite control and heartworm prevention), while farm animal products include the therapeutic anti-infective Denagard, an antimicrobial used to treat and control bacteria in swine, CLiK, an insect growth regulator used to control blowfly strike in sheep, cattle vaccines used to prevent respiratory and reproductive diseases in beef and dairy cattle, and Zolvix, a sheep drench representing the new sheep anthelmintic class. Aquaculture products include vaccines and treatments mainly used in salmon farming.

Advisors’ Opinion:

  • [By Jayson Derrick]

    Novartis’ (NYSE: NVS) Jakavi treatment has achieved its main goal in a Phase III trial of maintaining red-blood cell volume in patients with polycythemia vera, a deadly form of cancer. Shares lost 0.81 percent, closing at $83.14.

  • [By Patricio Kehoe]

    Johnson & Johnson (JNJ) comes in next, the fund owning over 235,000 shares, worth $21.5 million. The company operates in a highly competitive industry, including companies such as Novartis AG (NVS) and Pfizer Inc. (PFE). The company reported earnings per share increased by 32.5% compared to the same quarter one year prior, and has demonstrated a pattern of positive earnings per share growth over the past two years. The company returns cash to investors, and its current dividend yield is 2.83%, which is considered quite enough to protect the purchasing power.

Top 10 Companies To Invest In Right Now: PFSweb Inc.(PFSW)

PFSweb, Inc. provides business process outsourcing and ecommerce solutions in the United States, Canada, and Europe. It offers digital marketing services comprising search engine optimization, pay-per-click, affiliate marketing, comparison shopping engines, merchandising, Web analytics, customer experience, email marketing, and social media; and ecommerce technology services, including End2End eCommerce solution for the direct-to-consumer (DTC) and business-to-business (B2B) online channels. The company also provides order management services consisting of order management interfaces, collaboration technologies, and information management services; customer care services, including customer relationship management, customer order assistance, quality monitoring, and interactive voice response; and logistics and fulfillment services comprising distribution facilities and infrastructure, facility operations and management, kitting and assembly, and product management and insp ection. In addition, it offers financial management services consisting of billing, credit, collection, and cash application services for B2B clients, as well as fraud review, chargeback management, and processing and settlement credit card services for DTC clients; and professional consulting services in the areas of interactive marketing ecommerce, supply chain management, distribution and fulfillment, technology interfacing, logistics, and customer support. Further, the company provides seller services financial models, including enablement financial, agent or flash financial, and retail financial models. It serves fashion apparel and accessories, fragrance and beauty products, consumer packaged goods, home furnishings and housewares, consumer electronics, office technology and network connectivity products, and aviation spare parts industries. The company was founded in 1999 and is headquartered in Allen, Texas.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Leading and Lagging Sectors
    Technology stocks gained Thursday, with Infinera (NASDAQ: INFN) leading advancers. Meanwhile, gainers in the sector included LiveDeal (NASDAQ: LIVE), with shares up 5.5 percent, and PFSweb (NASDAQ: PFSW), with shares up 5.4 percent.

Top 10 Companies To Invest In Right Now: Sao Martinho SA (SMTO3)

Sao Martinho SA is a Brazil-based holding company primarily engaged in the sale and production of sugar and ethanol. It is engaged in the cultivation of sugar cane and production and sale of sugar, ethanol and other sugar cane products. The Company is also involved in the cogeneration of electricity and cattle breeding, as well as the provision of agricultural products. The Company produces hydrous ethanol, anhydrous ethanol, industrial ethanol, ribonucleic acid, fuel oil, yeast, sugar and sugarcane biogases, used to generate steam and electricity. Through its subsidiary Omtek, the Company produces ribonucleic acid (RNA) sodium salt, which is used in the pharmaceutical and food industries as a raw material and flavor enhancer. The Company operates through a numerous subsidiaries, including Vale do Mogi Empreendimentos Imobiliarios SA, SMA Industria Quimica SA, Usina Santa Luiza SA, Sao Martinho Energia SA and Santa Cruz SA, among others. Advisors’ Opinion:

  • [By Ney Hayashi]

    Sugar and ethanol producer Sao Martinho SA (SMTO3) fell 1.8 percent to 25.53 reais after posting a quarterly profit that missed analysts’ estimates.

Top 10 Companies To Invest In Right Now: Yoc AG (YOC)

Yoc AG is a German provider of mobile marketing and e-mail marketing service. It operates through two main segments: Mobile Technology and Media. The Mobile Technology segment encompasses the product areas Mobile Marketing and Mobile Internet, as well as the unit Mobile Business-to-Consumer (B2C). It also includes the licensing and implementation of technological products for target-oriented communication via mobile end devices. The Media segment covers the marketing of mobile websites and applications on Cost-per-thousand-impressions (CPM), media penetration and performance basis. The Company serves clients from the consumer goods, automobile, trading and service industries. The Company offers its clients advertising campaigns that integrate mobile phones and the Internet into classic advertising. As of December 31, 2011, it operated through 11 subsidiaries located in Germany, the United Kingdom, Belgium, Austria and France. Advisors’ Opinion:

  • [By Sofia Horta e Costa]

    ThyssenKrupp AG (TKA), Germany’s largest steelmaker, rose to a five-week high. YOC AG (YOC) surged the most in more than three months after the mobile-phone advertising company said it sold 1.3 million euros ($1.7 million) of shares to increase capital. Lanxess AG (LXS), the chemical maker that joined the DAX in September, retreated 3.4 percent.

Top 10 Companies To Invest In Right Now: Remy International Inc (REMY)

Remy International, Inc. (Remy), incorporated on November 22, 1993, is a global vehicular parts designer, manufacturer, remanufacturer, marketer and distributor of aftermarket and original equipment electrical components for automobiles, light trucks, heavy-duty trucks and other vehicles. Remy sells its products worldwide primarily under the Delco Remy, Remy, and World Wide Automotive brand names. The Company’s products include light-duty and heavy-duty starters and alternators for both the original equipment and the remanufactured markets, and hybrid power technology. These products are principally sold or distributed to original equipment manufacturers (OEMs) for both original equipment manufacture and aftermarket operations, as well as to warehouse distributors and retail automotive parts chains. The Company sells its products principally in North America, Europe, Latin America and Asia-Pacific. In January 2014, Remy International, Inc. acquired all assets of USA Indu stries.

The Company’s original equipment division consists of three primary channels: automotive, heavy-duty vehicles and electric motors for electric and hybrid applications. Remy is a supplier for such original equipment manufacturers as General Motors, DaimlerChrylser, Toyota, Honda and Hyundai/Kia. The Company is a supplier of original equipment and aftermarket starters and alternators for heavy-duty vehicles in North America. Remy is an independent production electric motor supplier and in many aspects of hybrid and electric vehicle technology, including the patented hairpin stator technology. Its original equipment (OE) business has operations in the United States, Mexico, Brazil, China and Korea.

Advisors’ Opinion:

  • [By Rich Smith]

    On Monday, auto parts maker Remy International (NASDAQ: REMY  ) announced that it is taking 100% control of its Remy Hubei Electric Co. (REH) joint venture, buying out partner Hubei Super Electric Auto Motor Company’s 49% interest in the JV.

Top 10 Companies To Invest In Right Now: Gold Fields Ltd (GFI)

Gold Fields Limited (Gold Fields) is a holding company. Gold Fields is engaged in gold mining and related activities, including exploration, extraction, processing and smelting. Gold Fields is a producer of gold and holder of gold reserves in South Africa, Ghana, Australia and Peru. In Peru, Gold Fields also produces copper. Gold Fields is primarily involved in underground and surface gold and copper mining and related activities. Gold Fields also has an interest in a platinum group metal exploration project in Finland. Gold bullion is its principal product, which is produced in South Africa, Ghana and Australia and sold in South Africa and internationally. In addition, Gold Fields has gold and other precious metal exploration activities and interests in Africa, Eurasia, Australasia and the Americas. The Company holds 34.9% interest in Rand Refinery Limited.

On June 22, 2011, Gold Fields acquired the 18.9% interest of IAMGold Corporation (IAMGold), which incr eased Gold Fields’ interest in each of the Tarkwa and Damang gold mines from 71.1% to 90.0%. On April 15, 2011, it acquired further interest in Gold Fields La Cima S.A.A. (La Cima). During the year ended December 31, 2011, the Company acquired a 21.8% interest in Timpetra Resources Limited.

KDC Operation

The KDC mine is located in the Gauteng Province of South Africa in the Far West Rand mining district, some 60 kilometers southwest of Johannesburg. KDC is consists of the Driefontein and Kloof mines. In 2011, KDC produced 1.1 million ounces of gold. KDC is consists of 13 producing shaft systems that mine different contributions from pillars and open ground, five gold plants of which two process mainly underground ore and three process mainly surface material. The KDC operation is engaged in both underground and rock dump mining. In total, during 2011, there were 13 fatalities at KDC. Of these, five were due to seismic related falls of ground, fiv e resulted from gravity related falls of ground, two related! to tramming operations and one related to a person falling from height.

Beatrix Operation

The Beatrix operation is located in the Free State Province of South Africa, some 240 kilometers southwest of Johannesburg, near Welkom and Virginia, and consists of the Beatrix mine. Beatrix operates under mining rights covering a total area of approximately 16,800 hectares. Beatrix is an underground only operation. Beatrix has four shaft systems, with five ventilation shafts to provide additional up-cast and down-cast ventilation capacity and is serviced by two metallurgical plants. It is a shallow to intermediate-depth mining operation, at depths between 700 meters and 2,200 meters below surface. In 2011, Beatrix produced 0.347 million ounces of gold. Beatrix is managed as three operational sections: the North Section, the South Section and the West Section. The Beatrix mine is engaged in underground and surface mining. It had five fatalities at Beatrix, in 2011.

South Deep Operation

South Deep is situated adjacent to KDC, in the Gauteng Province of South Africa. South Deep is a capital project and remains a developing mine. South Deep is engaged in underground mining and is consists of one metallurgical plant and two operating shaft systems, the older South Shaft complex and the newer Twin Shaft complex. The South Shaft complex includes a main shaft and three sub-vertical (SV) shafts, two of which are operational. The Twin Shaft complex consists of a single-barrel shaft and an adjacent bratticed ventilation shaft, or the Twins Main Ventilation Shaft. While the Twin Shaft complex forms the center of production and capital development activities, opening up, equipping and diamond drilling operations are being conducted in the South Shaft area in order to access new mining areas.

The South Shaft complex operates to a depth of 2,650 meters below surface and the Twin Shaft complex operates t o a depth of 2,995 meters below surface. In 2011, South Deep! produced! 0.273 million ounces of gold. During 2011, the South Deep plant treated an average of 0.2 million tons per month (excluding Kloof mine toll treatment) consisted of an average of 167,000 tons per month of underground material and 31,000 tons per month of surface material from South Deep.

Ghana Operations

Gold Fields Ghana Limited (Gold Fields Ghana), which holds the interest in the Tarkwa mine. The Tarkwa mine is located in southwestern Ghana, about 300 kilometers by road west of Accra. The Tarkwa mine consists of several open pit operations on the original Tarkwa property and the adjacent southern portion of the property, together with a heap leach facility, referred to as the North Plant Heap Leach Facility. The capacity of the facility is 3.3 million tons per annum. The total treatment capacity including the North Plant, the High Pressure Grinding Roll Facility and the carbon in leach (CIL) Plant is estimated to be 24 million tons per annum. The Tarkwa mine operates under mining leases with a total area of approximately 20,800 hectares, the entirety of which are surface operations. In 2011, Tarkwa produced 0.717 million ounces of gold, of which 0.576 million ounces were attributable to Gold Fields.

Abosso Goldfields Limited (Abosso), which owns the interest in the Damang mine. The Damang deposits are located in the Wassa West District in southwestern Ghana approximately 330 kilometers by road west of Accra and approximately 30 kilometers by road northeast of the Tarkwa mine. The Damang mine consists of an open pit operation with a semi-autogenous grinding (SAG) mill and CIL processing plant. Damang operates under a mining lease with a total area of approximately 8,100 hectares. In 2011, the Damang mine produced 0.218 million ounces of gold, of which 0.175 million ounces.

Australia Operations

Gold Fields owns the St. Ives and Agnew gold mining operations in Australia. St. Ives i s located 80 kilometers south of Kalgoorlie and 20 kilometer! s south o! f Kambalda, straddling Lake Lefroy in Western Australia. It holds exploration licenses, prospecting licenses and mining leases covering a total area of approximately 97,700 hectares. St. Ives is both a surface and underground operation, with a number of open pits, four operating underground mines, a metallurgical carbon in pulp (CIP) plant and a heap leach facility. In 2011, St. Ives produced 0.465 million ounces of gold. St. Ives sources production from a variety of underground and surface operations. Exploration activities are continuing with a view to extending the life of the mine.

Production at the Argo underground mine continued throughout, during 2011. Greater Revenge Complex operation utilizes open pit and lake sediment mining methods. Cutbacks of the Agamemnon and Mars Minotaur Link pits were mined, during 2011. The Belleisle deposit lies in the Greater Revenge Area adjacent to the depleted Mars open pit. The final 20,000 ounces were mined from Belleisl e, in 2011 and the mine was closed, in May 2011. Cave Rocks is located approximately six kilometers to the west of the Kambalda West township. The Leviathan open pit is based on the expansion of a pre-existing open pit located approximately two kilometers southeast of the Lefroy processing plant. The mine utilizes conventional truck and shovel mining practices.

Construction at the Athena mine reached commercial levels of production, in July 2011. The first ore extraction from Hamlet occurred, in November 2011. As of December 31, 2011, Athena ahd a life of mine of four years and Hamlet had a life of seven years with prospects of extensions to those lives. Underground mining activities at Belleisle, Cave Rocks and Argo were undertaken under an agreement with Carlowen Proprietary Ltd, which trades as GBF Underground Mining (GBF). Leighton Contractors Proprietary Limited (Leighton) performs the surface mining at St. Ives under an alliance agreement. Leighton provid es employees and equipment for mining ore and waste from the! open pit! mines. Agnew is located 23 kilometers west of Leinster, approximately 375 kilometers north of Kalgoorlie and 630 kilometers northwest of Perth, Western Australia.

The Company holds exploration licenses, prospecting licenses and mining leases covering a total area of approximately 54,000 hectares. Agnew operated both an underground and the Songvang open pit, in 2011. Underground mining is conducted from the Waroonga Underground Complex which consists of multiple ore zones. Agnew has one metallurgical plant. Agnew is serviced by sealed road infrastructure to the mine gate. In 2011, the operation produced 0.194 million ounces of gold. The principal production source, in 2011, at Agnew was the Waroonga underground mining complex. The northern cutback of the Songvang open pit commenced, in 2011. The Waroonga Underground Complex includes underground mining of the Kim South, Rajah and Main Lode ore bodies. The mining method involves longhole open stoping with paste fi lling. Waroonga underground performance averaged 52,000 tons per month, in 2011.

Peru Operation

Gold Fields owns 98.5% economic interest in the Cerro Corona mine through its shareholding in La Cima. Cerro Corona mine forms part of a porphyry copper-gold deposit situated within the Hualgayoc Mining District in northern Peru. It is located in the part of the Western Cordillera of the Andes, in northern Peru, close to the headwaters of the Atlantic continental basin. Cerro Corona is located approximately 80 kilometers by road north of the City of Cajamarca. Cerro Corona holds mining leases covering a total area of approximately 1,600 hectares and the project was developed over an area of 940 hectares. In 2011, the operation produced 0.161 million ounces of gold and 38,641 tons of copper for a total of 0.383 million gold equivalent ounces, of which 0.159 million ounces of gold and 38,061 tons of copper for a total of 0.377 million gold equivalent ounces were attributable to Gold Fields.

Advisors’ Opinion:

  • [By Patricio Kehoe] ty of the Toronto-based miner’s assets contain refractory ore, which is far more expensive to extract than non refractory ore. And, in an attempt to switch production to the lower cost gold ore, and thus increase margins, Golden Star has depleted its mines’ non refractory ore. With low reserves and mounting cash costs, the firm inevitably turned to new acquisitions.

    Overpriced Acquisitions and Geopolitical Risk

    The purchase of new assets, which recently turned out to be overvalued due to the drop in gold prices, is haunting Golden Star. Impairment costs and low operating margins stemming from the acquisition of overpriced mines, has resulted in significant financial losses. In addition, the company faces considerable geopolitical risks. Ghana’s government has not only seen political unrest, but also has a 10% stake in the Bogoso and Wassa mines. Shareholders are naturally uneasy about government involvement in Golden Star’s operations, especially d ue to the volatility of the region. By concentrating all of its assets in Ghana, the firm’s risk profile has increased significantly.

    Bottom Line

    Apart from mounting debt levels and shrinking margins, the firm’s operational problems and poor product mix shifts, have led to recurring operating losses. Also, as cash flows are nullified, new acquisitions are not feasible. Unlike other troubled competitors such as Barrick Gold Corp (ABX), Golden Star’s balance sheet is simply not strong enough to deal with so many set-backs. Hence, it comes as little surprise that previously bullish gurus have recently sold their entire stake in the firm. I would do the same, as this company’s future is not only grim, but could even include bankruptcy in the near future due to a lack of funds.

    Disclosure: Patricio Kehoe holds no position in any stocks mentioned.

    Also check out: Arnold Schneider Undervalued Stocks Arnold Schneider Top Growth Companies Arnold Schneider H

  • [By Jonathan Yates]

    And this news now results in dividend-paying gold stocks, such as Yamana Gold (NYSE: AUY), Gold Fields (NYSE: GFI) and Newmont Mining (NYSE: NEM) being attractive as both short-term and long-term investments.

  • [By Daniel Putnam]

    First, and most important, earnings estimates are stabilizing. In the past sixty days, 2013 estimates for the major gold miners have begun to tick up. In most cases, the increase is very modest. For instance, Goldcorp‘s (GG) EPS estimates have climbed from $0.91 to $0.95, while Barrick Gold‘s (ABX) have inched up from $2.57 to $2.64. Newmont Mining (NEM), Anglogold Ashanti (AU), and Gold Fields Ltd. (GFI) have shown similar gains. This positive rate of change marks a significant departure from the steady stream of bad news investors have had to endure in recent years.

  • [By Ben Levisohn]

    As a result, Chidley and team upgraded Agnico Eagle Mines (AEM) and Yamana Gold (AUY) to Neutral from Underweight, and raised Barrick Gold (ABX), Goldcorp (GG) and Iamgold (IAG) to Overweight from Neutral. Gold Fields (GFI) was downgraded “due to increased risk and also reduced expectations for the South Deep operation,” Chidley says.

Top 10 Companies To Invest In Right Now: GSV Capital Corp (GSVC)

GSV Capital Corp. (GSV Capital), formerly NeXt Innovation Corp., is a development-stage company. The Company is an externally managed, non-diversified closed-end management investment company. The Company’s investment objective is to maximize capital appreciation. The Company will seek to achieve its investment objective by investing primarily in privately held high growth venture backed companies and select mid cap and large cap publicly traded companies.

The Company may also invest in select publicly-traded equity securities of companies that otherwise meet its investment criteria. It seeks to acquire its investments primarily through private secondary market transactions and, to a lesser extent, through transactions executed on public securities exchanges and direct investments in its portfolio companies. The Company’s investment activities will be managed by GSV Asset Management. GSV Capital Service Company will provide the administrative services.

Advisors’ Opinion:

  • [By Jake L’Ecuyer]

    Financial sector was the leading decliner in the US market today. Top losers in the sector included GSV Capital (NASDAQ: GSVC), off 9.3 percent, and Cninsure (NASDAQ: CISG), down around 6.6 percent.

  • [By Jon C. Ogg]

    Chegg, Inc. (NYSE: CHGG) was the IPO disappointment of the week. Sure it has a lot of competition, but IPOs are supposed to be on fire now. Chegg managed to gain almost 3% on Friday to close at $9.13, but one must remember that the IPO price at $12.50 never saw the $12.50 open. The stock opened at $9.80 and closed at $8.88 on the first day, a move which will baffle IPO investors of growth companies who are buying an IPO at a time when major indexes are hitting new all-time highs. By the way, GSV Capital Corp. (NASDAQ: GSVC) was a runner-up loser along with Chegg, as this fund owned shares of Twitter and Chegg pre-IPO. The stock price was above $16 before the Twitter IPO and is now down to $12.03 after another 8.8% drop on Friday. Bye-bye.

Top 10 Companies To Invest In Right Now: MWI Veterinary Supply Inc.(MWIV)

MWI Veterinary Supply, Inc., together with its subsidiaries, engages in the distribution of animal health products to veterinarians in the United States and the United Kingdom. It primarily offers pharmaceuticals, vaccines, parasiticides, diagnostics, capital equipment, supplies, specialty products, veterinary pet food, and nutritional products. The company?s pharmaceutical products include anesthetics, analgesics, antibiotics, ophthalmics, and hormones; vaccine products consist of small animal, equine, and production animal biologicals; and parasiticides are used for control of fleas, ticks, flies, mosquitoes, and internal parasites. Its diagnostics products comprise consumable in-clinic tests for detecting heartworm, lyme, feline leukemia, and parvovirus, as well as consumable products for measuring blood chemistry, electrolyte balance, and cell counts; capital equipment products include anesthesia machines, surgical monitors, diagnostic equipment, dental machines, cage s, lights, and x-ray machines; and supplies consists of syringes, instruments, bandages, IV products, surgical consumables, grooming materials, and other small equipment items. The company?s veterinary pet foods products include foods for specialty diets and premium pet foods; and nutritional products comprise dietary supplements, vitamins, dental chews, and specialty treats. As of September 30, 2011, it served approximately 24,000 veterinary practices in the United States; and 1,500 veterinary practices in the United Kingdom. The company was formerly known as MWI Holdings, Inc. and changed its name to MWI Veterinary Supply, Inc. in April 2005. MWI Veterinary Supply, Inc. was founded in 1976 and is headquartered in Boise, Idaho.

Advisors’ Opinion:

  • [By Seth Jayson]

    Calling all cash flows
    When you are trying to buy the market’s best stocks, it’s worth checking up on your companies’ free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That’s what we do with this series. Today, we’re checking in on MWI Veterinary Supply (Nasdaq: MWIV  ) , whose recent revenue and earnings are plotted below.

  • [By Rupert Hargreaves]

    Pet-related companies are highly sought after
    Having said that, it would appear that in comparison to the rest of the pet-related sector, Zoetis is fairly valued. Peer MWI Veterinary Supply (NASDAQ: MWIV  ) trades at 27 times forward earnings, and again the company is highly defensive, engaging in the distribution of animal health products to veterinarians in the United States and the United Kingdom. Veterinary supply is exposed to the same demand factors as Zoetis — greater demand for animal treatments will lead to more demand for the distribution of animal health products.

  • [By Ben Levisohn]

    Overvalued companies include MWI Veterinary (MWIV) and Stericycle (SRCL), while companies with attractive valuations include Cardinal Health (CAH), Selected Medical (SEM). He’s not a fan of Intrexon (XON) but calls Aratana (PETX) a “hidden gem.”